KP-544
| Code | Size | Price |
|---|
| TAR-T24268-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
KP-544 is an agent of neurotrophin potentiator.
CAS:
393856-87-6
Formula:
C18H19ClN4O
Molecular Weight:
342.83
Purity:
0.98
SMILES:
Nc1ncc(C#Cc2ccc(Cl)cc2)c(N[C@H]2CC[C@H](O)CC2)n1
References
1. Dey ND, Boersen AJ, Myers RA, York LR, Bombard MC, Lu M, Sandstrom MI, Hulce VD, Lescaudron L, Dunbar GL. The novel substituted pyrimidine, KP544, reduces motor deficits in the R6/2 transgenic mouse model of Huntington's disease. Restor Neurol Neurosci. 2007;25(5-6):485-92. PubMed PMID: 18334766.
2. Geist MA, Volbracht C, Podhorna J, Falsig J, Leist M. Wide spectrum modulation by KP-544 in models relevant for neuronal survival. Neuroreport. 2007 Apr 16;18(6):571-5. PubMed PMID: 17413659.